In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...

Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said Friday its chief executive was stepping down in the wake of "market challenges".

Discover why Novo Nordisk A/S' undervalued shares present a buying opportunity, with strong sales growth, profitability, and ...

Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its ...

Having dedicated the book to his late father Dr. Michael Mosley, a much-loved fixture on our screens and airwaves whose work ...

Novo’s shares have plunged since hitting a record-high in June last year as competition, particularly from Eli Lilly, makes inroads into its market share and as its pipeline of new drugs has ...

Lars Fruergaard Jorgensen, the chief executive of once-highflying Danish drugmaker Novo Nordisk, is stepping down after eight ...

The cost of illegal immigration is a hot-button issue – and Democrats have a wide range of reactions. In this video, we break down how Democratic leaders and voters are responding to the economic, ...

The maker of Ozempic and Wegovy expects lower sales and profit growth this year despite recent victories against compounders.

Ozempic (semaglutide) is a medication approved by the Food and Drug Administration (FDA) to treat type 2 diabetes. Because Ozempic has been shown to boost weight loss in people with diabetes, it ...

Medications taken for weight loss are starting to impact wedding planning — and ... loss drugs like Zepbound and diabetes drugs like Ozempic and Mounjaro that are often used for weight loss.

Ozempic and Wegovy are effective for weight ... further investigation is needed to understand their potential impact on mental health. As per a news release, the study, led by researchers across ...